BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26512779)

  • 1. Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells.
    Qin Y; Zhang Q; Lee S; Zhong WL; Liu YR; Liu HJ; Zhao D; Chen S; Xiao T; Meng J; Jing XS; Wang J; Sun B; Dai TT; Yang C; Sun T; Zhou HG
    Oncotarget; 2015 Dec; 6(38):40667-79. PubMed ID: 26512779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to Gefitinib.
    Ming JX; Wang ZC; Huang Y; Ohishi H; Wu RJ; Shao Y; Wang H; Qin MY; Wu ZL; Li YY; Chang Zhou S; Chen H; Liu H; Xu R
    J Ethnopharmacol; 2021 Jan; 265():113302. PubMed ID: 32860893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.
    Han D; Wu G; Chang C; Zhu F; Xiao Y; Li Q; Zhang T; Zhang L
    Oncotarget; 2015 Dec; 6(38):40907-19. PubMed ID: 26517513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-GO@XN nanocomposite suppresses breast cancer metastasis via inhibition of mitochondrial oxidative phosphorylation and blockade of epithelial-to-mesenchymal transition.
    Zhang J; Yan L; Wei P; Zhou R; Hua C; Xiao M; Tu Y; Gu Z; Wei T
    Eur J Pharmacol; 2021 Mar; 895():173866. PubMed ID: 33454376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy.
    Wang P; Yang X; Xu W; Li K; Chu Y; Xiong S
    Cancer Immunol Immunother; 2010 Nov; 59(11):1715-26. PubMed ID: 20706716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation, Characterization, and Application of Inducible Proliferative Adult Human Epicardium-Derived Cells.
    Ge Y; Smits AM; Liu J; Zhang J; van Brakel TJ; Goumans MJTH; Jongbloed MRM; de Vries AAF
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Chromosomal Gains Can Function as Metastasis Suppressors and Promoters in Colon Cancer.
    Vasudevan A; Baruah PS; Smith JC; Wang Z; Sayles NM; Andrews P; Kendall J; Leu J; Chunduri NK; Levy D; Wigler M; Storchová Z; Sheltzer JM
    Dev Cell; 2020 Feb; 52(4):413-428.e6. PubMed ID: 32097652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EVT-701 is a novel selective and safe mitochondrial complex 1 inhibitor with potent anti-tumor activity in models of solid cancers.
    Luna Yolba R; Visentin V; Hervé C; Chiche J; Ricci JE; Méneyrol J; Paillasse MR; Alet N
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00854. PubMed ID: 34478236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Combination of Three Natural Compounds Effectively Prevented Lung Carcinogenesis by Optimal Wound Healing.
    Liu L; Li H; Guo Z; Ma X; Cao N; Zheng Y; Geng S; Duan Y; Han G; Du G
    PLoS One; 2015; 10(11):e0143438. PubMed ID: 26599445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pillar-Based Mechanical Induction of an Aggressive Tumorigenic Lung Cancer Cell Model.
    Lee G; Cho Y; Kim EH; Choi JM; Chae SS; Lee MG; Kim J; Choi WJ; Kwon J; Han EH; Kim SH; Park S; Chung YH; Chi SG; Jung BH; Shin JH; Lee JO
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):20-31. PubMed ID: 34914354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of SH2B3 by SMYD5 controls epithelial-mesenchymal transition in lung cancer.
    Tae IH; Ryu TY; Kang Y; Lee J; Kim K; Lee JM; Kim HW; Ko JH; Kim DS; Son MY; Cho HS
    Mol Cells; 2024 May; ():100067. PubMed ID: 38723947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.
    Fischer KR; Durrans A; Lee S; Sheng J; Li F; Wong ST; Choi H; El Rayes T; Ryu S; Troeger J; Schwabe RF; Vahdat LT; Altorki NK; Mittal V; Gao D
    Nature; 2015 Nov; 527(7579):472-6. PubMed ID: 26560033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline inhibits proliferation and induces apoptosis of both human papillomavirus positive and negative cervical cancer cell lines.
    Zhao Y; Wang X; Li L; Li C
    Can J Physiol Pharmacol; 2016 May; 94(5):526-33. PubMed ID: 26913972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New application of an old drug: Antitumor activity and mechanisms of doxycycline in small cell lung cancer.
    Wang SQ; Zhao BX; Liu Y; Wang YT; Liang QY; Cai Y; Zhang YQ; Yang JH; Song ZH; Li GF
    Int J Oncol; 2016 Apr; 48(4):1353-60. PubMed ID: 26846275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway.
    Lee MH; Kachroo P; Pagano PC; Yanagawa J; Wang G; Walser TC; Krysan K; Sharma S; John MS; Dubinett SM; Lee JM
    J Cancer Sci Ther; 2014 Nov; 6(11):468-477. PubMed ID: 26523208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl oxidase mediates hypoxia-induced radioresistance in non-small cell lung cancer A549 cells.
    Gong C; Gu R; Jin H; Sun Y; Li Z; Chen J; Wu G
    Exp Biol Med (Maywood); 2016 Feb; 241(4):387-95. PubMed ID: 26515140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs).
    Fiorillo M; Tóth F; Sotgia F; Lisanti MP
    Aging (Albany NY); 2019 Apr; 11(8):2202-2216. PubMed ID: 31002656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway.
    Zhong W; Chen S; Qin Y; Zhang H; Wang H; Meng J; Huai L; Zhang Q; Yin T; Lei Y; Han J; He L; Sun B; Liu H; Liu Y; Zhou H; Sun T; Yang C
    Oncotarget; 2017 Dec; 8(62):104855-104866. PubMed ID: 29285218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
    Zhang L; Xu L; Zhang F; Vlashi E
    Cell Cycle; 2017 Apr; 16(8):737-745. PubMed ID: 27753527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma U-87 cell electrotaxis is hindered by doxycycline with a concomitant reduction in the matrix metallopeptidase-9 expression.
    Chang HF; Cheng JY
    Biochem Biophys Rep; 2024 Jul; 38():101690. PubMed ID: 38571555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.